# LYNOZYFIC
> **BLA761400** · Biologics License Application · Sponsor: RENGENERON PHARMACEUTICALS, INC. · Approved 2025-07-02
## Drug
- **FDA Application Number:** BLA761400
- **Application type:** Biologics License Application
- **Brand name:** LYNOZYFIC
- **Generic name:** LINVOSELTAMAB-GCPT
- **Active ingredients:** LINVOSELTAMAB-GCPT
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** RENGENERON PHARMACEUTICALS, INC.
- **Manufacturer:** Regeneron Pharmaceuticals, Inc.
- **First approval:** 2025-07-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761400)
---
*MORVS · CC0 1.0*